TNF and rheumatoid arthritis: The rationale for developing anti-TNFα treatments in RA is based on multiple in vitro and in vivo studies, showing the excessive stimulatory effect of TNFα on a wide range of biological processes leading to increased inflammation and tissue destruction [3,4].